Gheorghe A, Sima O, Florescu A, Ciuche A, Nistor C, Sandru F
Int J Mol Sci. 2024; 25(4).
PMID: 38396977
PMC: 10889221.
DOI: 10.3390/ijms25042301.
Mazarico-Altisent I, Capel I, Baena N, Bella-Cueto M, Barcons S, Guirao X
Front Endocrinol (Lausanne). 2023; 14:1244361.
PMID: 37810884
PMC: 10558207.
DOI: 10.3389/fendo.2023.1244361.
Mahamad Apandi N, Basri N, Jalil A, Jelon M
Case Rep Dent. 2023; 2023:4664619.
PMID: 36937223
PMC: 10017210.
DOI: 10.1155/2023/4664619.
Minisola S, Arnold A, Belaya Z, Brandi M, Clarke B, Hannan F
J Bone Miner Res. 2022; 37(11):2315-2329.
PMID: 36245271
PMC: 10092691.
DOI: 10.1002/jbmr.4665.
Palmieri S, Grassi G, Guarnieri V, Chiodini I, Arosio M, Eller-Vainicher C
Front Med (Lausanne). 2022; 8:809067.
PMID: 35141253
PMC: 8818680.
DOI: 10.3389/fmed.2021.809067.
A contemporary clinical approach to genetic testing for heritable hyperparathyroidism syndromes.
De Sousa S, Carroll R, Henderson A, Burgess J, Clifton-Bligh R
Endocrine. 2021; 75(1):23-32.
PMID: 34773560
DOI: 10.1007/s12020-021-02927-3.
Discovering Myeloid Cell Heterogeneity in Mandibular Bone - Cell by Cell Analysis.
Kwack K, Lamb N, Bard J, Kramer E, Zhang L, Abrams S
Front Physiol. 2021; 12:731549.
PMID: 34658914
PMC: 8514701.
DOI: 10.3389/fphys.2021.731549.
Familial Hyperparathyroidism.
Blau J, Simonds W
Front Endocrinol (Lausanne). 2021; 12:623667.
PMID: 33716975
PMC: 7947864.
DOI: 10.3389/fendo.2021.623667.
Imaging technologies in the differential diagnosis and follow-up of brown tumor in primary hyperparathyroidism: Case report and review of the literature.
Diacinti D, Cipriani C, Biamonte F, Pepe J, Colangelo L, Kripa E
Bone Rep. 2021; 14:100745.
PMID: 33506077
PMC: 7815655.
DOI: 10.1016/j.bonr.2020.100745.
Ossifying fibroma of the jaw bones in hyperparathyroidism-jaw tumor syndrome: Analysis of 24 cases retrieved from literatures.
Ibrahem H
J Dent Sci. 2021; 15(4):426-432.
PMID: 33505612
PMC: 7816022.
DOI: 10.1016/j.jds.2019.12.007.
Clinical and Molecular Genetics of Primary Hyperparathyroidism.
Simonds W
Horm Metab Res. 2020; 52(8):578-587.
PMID: 32227318
PMC: 9361404.
DOI: 10.1055/a-1132-6223.
OVARIAN GRANULOSA CELL TUMOR IN A PATIENT WITH A PATHOGENIC VARIANT IN THE GENE (HYPERPARATHYROIDISM-JAW TUMOR SYNDROME).
Sirbiladze R, Uyar D, Geurts J, Shaker J
AACE Clin Case Rep. 2020; 5(3):e222-e225.
PMID: 31967039
PMC: 6876943.
DOI: 10.4158/ACCR-2018-0555.
Strontium enhances proliferation and osteogenic behavior of bone marrow stromal cells of mesenchymal and ectomesenchymal origins in vitro.
Bizelli-Silveira C, Abildtrup L, Spin-Neto R, Foss M, Soballe K, Christian Evar Kraft D
Clin Exp Dent Res. 2019; 5(5):541-550.
PMID: 31687189
PMC: 6820574.
DOI: 10.1002/cre2.221.
Multiple Endocrine Neoplasia Type 1 (MEN1): An Update and the Significance of Early Genetic and Clinical Diagnosis.
Kamilaris C, Stratakis C
Front Endocrinol (Lausanne). 2019; 10:339.
PMID: 31263451
PMC: 6584804.
DOI: 10.3389/fendo.2019.00339.
Current concepts in parathyroid carcinoma: a single Centre experience.
Ferraro V, Sgaramella L, Di Meo G, Prete F, Logoluso F, Minerva F
BMC Endocr Disord. 2019; 19(Suppl 1):46.
PMID: 31142320
PMC: 6541564.
DOI: 10.1186/s12902-019-0368-1.
MicroRNA-705 regulates the differentiation of mouse mandible bone marrow mesenchymal stem cells.
Yang X, Yang K, An Y, Wang L, Luo G, Hu X
PeerJ. 2019; 7:e6279.
PMID: 30648022
PMC: 6330203.
DOI: 10.7717/peerj.6279.
Evolution of Our Understanding of the Hyperparathyroid Syndromes: A Historical Perspective.
Marx S, Goltzman D
J Bone Miner Res. 2018; 34(1):22-37.
PMID: 30536424
PMC: 6396287.
DOI: 10.1002/jbmr.3650.
Brown tumor of multiple facial bones associated with primary hyperparathyroidism: A clinical case report.
Zou H, Song L, Jia M, Wang L, Sun Y
Medicine (Baltimore). 2018; 97(33):e11877.
PMID: 30113484
PMC: 6112971.
DOI: 10.1097/MD.0000000000011877.
Hyperparathyroidism-Jaw Tumor Syndrome Associated With Large-Scale 1q31 Deletion.
Rubinstein J, Majumdar S, Laskin W, Lazaga F, Prasad M, Carling T
J Endocr Soc. 2017; 1(7):926-930.
PMID: 29264543
PMC: 5686645.
DOI: 10.1210/js.2016-1089.
Familial isolated primary hyperparathyroidism associated with germline GCM2 mutations is more aggressive and has a lesser rate of biochemical cure.
El Lakis M, Nockel P, Guan B, Agarwal S, Welch J, Simonds W
Surgery. 2017; 163(1):31-34.
PMID: 29108698
PMC: 5736428.
DOI: 10.1016/j.surg.2017.04.027.
